DIANT Pharma has developed a continuous processing technology applicable for nanoparticle therapeutics and vaccines. We strive to offer a technology that is robust and reliable from R&D to commercial manufacturing. Our proprietary continuous manufacturing system for nanoparticles has a wide array of applications within the pharmaceutical space and beyond.

DIANT Pharma

Pharmaceutical

Connecticut Innovations provides strategic capital and operational insight to push the frontiers of high-tech industries such as energy, biotechnology, information technology, and photonics. Over the years, CI has helped over 100 emerging companies research, develop, and market new products and services. This activity has attracted over $1 billion dollars in additional investments from private equity providers. CI has brought the State of Connecticut over $510 million in Gross State Profit and over 5,000 additional job-years.

Career Opportunities